23: Antipsychotics Flashcards

1
Q

Psychosis

A

abnormal condition of the mind

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Antipsychotic drugs

A

those to treat schizophrenia (also for mania and acute behavioral disturbances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

typical schizophrenia onset

A

20-30s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

positive symptoms include

A
delusions
hallucinations
thought disorder
abnormal disorganized disorders
catatonia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

negative symptoms include

A

withdrawal
flattening
anhedonia
reluctance to perform everyday tasks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

cognitive symptoms

A

deficits in function- attention, memory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

mesolimbic system is associated with + or - symptoms

A

+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

2 pathologies of + symptoms

A

overactivation of D2 receptors in mesolimbic pathway

NMDA receptor hypofunction on GABAergic neurons =no inhibition on DA neuron with GABA receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

pathology of - symptoms

A

decreased activity in D1 receptor pathways in mesocortical pathways. this is caused by NMDA receptor hypofunction on DA neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cognitive impairment caused by

A

NMDA receptor hypofunction on cortical GABAergic interneurons = alter cortical processing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

General mech of schizophrenia pharmacotherapy

A

antagonism of D2 DA receptors = relieve positive symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

therapeutic effects of medications require _____ D2 receptor occupancy

A

> 80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

are treatments better at + or - symptoms

A

+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

_____% of patient are treatment resistant

A

30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

chlorpromazine is a

A

1st generation drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

clozapine is a

A

2nd generation drug

17
Q

Similar selectivity for D2 nd D1 receptors
More extrapyramidal motor disturbances
Less effective against (-) symptoms

A

first generation

18
Q

More selective for D2
Less extrapyramidal motor disturbances
More effective against negative symptoms
Can sometimes work for treatment resistant pts

A

second generation

19
Q

motor disturbances are usually due to

A

block of D2 receptors in NS pathway

20
Q

extrapyramidal side effects also include

A

Slow developing, often irreversible dyskinesia (face, tongue, limbs)
More prolactin secretion and galactorrhea (excessive milk production in both females and males)
Due to block of D2 in tuberohypophyseal pathway
Reduced pleasure - D2 block in ML pathway
May potentially worsen (-) symptoms due to block of D2 receptors in cortex

21
Q

Antagonistic effects at other receptors

A

Antihistamine (h1) activity = sedation
mAchR inhibition
Alpha adrenoceptor blockade = orthostatic hypotension

22
Q

what can cause leukopenia/ agranulocytosis

A

clozapine

23
Q

what should you block when the D2 receptor is blocked and there is too much Ach release to prevent motor syndroms

A

mAchR

24
Q

how to enhance DA release in the striatum to reduce motor side effects

A

inhibit mAchRs on DA nerve terminals

25
Q

5HT2A receptors in the CNS can be

A

inhibitory- Gi coupled

26
Q

what do 5HT2A receptors do in the nigrostriatal pathway

A

inhibit DA release from DA neurons

27
Q

blocking ___ in stiatum ____ dopamine release, _____ motor side effects associated with striatal D2 receptor inhibition

A

mAChR
increases
reducing

28
Q

in mesocortical circuits, a 5HT2A receptor antagonist may

A

improve negative symptoms by enhancing DA and glu release

29
Q

in mesolimbic pathway combined ___ and ____ receptor antagonist can counteract increased dopamine function

A

D2 an 5HT2A